NM or Neisseria meningitidis is a close bacterial relative of Neisseria gonorrhoeae – the cause of gonorrhoea. In 2015, the NM bacterium mutated to start transferring more efficiently from one person to another via sexual contact. Since then, NM has turned into one of the previously rare STDs now on the rise.

Mycoplasma genitalium is not a well-known sexually transmitted infection. The problem with this STD is that few people know about it or have an idea about the best prevention and treatment options. It has also become apparent that mycoplasma genitalium infections are on the rise in various parts of the world.

The FDA in America has given its approval for new tests that can positively identify an STI-causing bacterium called Mycoplasma genitalium. The FDA approval came after 12,000 samples were examined and the reliability of the test was confirmed. Mycoplasma genitalium is known to cause urinary and reproductive tract infections. Until present, however, there was no reliable way to test for its presence. The early treatment of Mycoplasma genitalium infections is very important because in the long run, these could contribute to infertility or pregnancy complications.